Table of Contents
Table of Contents 3
List of Tables 6
List of Figures 7
Abbott Laboratories, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 8
Abbott Laboratories, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 9
Abbott Laboratories, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 10
Abbott Laboratories, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 11
Abbott Laboratories, Medical Devices Deals, 2011 to YTD 2017 13
Abbott Laboratories, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 14
Abbott Laboratories, Pharmaceuticals & Healthcare, Deal Details 20
Asset Purchase 20
Abbott Labs And Organon BioSciences Plan To Acquire Certain Pharma Assets From Johnson & Johnson 20
Thoratec Acquires DuraHeart II Ventricular Assist System From Terumo For US$56.5 Million 22
Abbott Labs Acquires AP214 From Action Pharma For US$110 Million 24
Venture Financing 26
NeuroGenetic Pharma Raises US$0.2 Million In Venture Financing 26
NeuroGenetic Pharma Secures Investment In Venture Financing 27
AuraSense Therapeutics Secures Investment In Series B Financing 28
Creabilis Secures US$20 Million In Series B Financing 29
AM-Pharma Secures US$39.7 Million In Series D Financing 30
Spinal Modulation Secures US$30 Million In Series D Financing 32
Private Equity 34
Sanofi Plans to Sell Portfolio of Mature Drugs for USD8.6 Billion 34
Partnerships 36
BioPorto Diagnostics Enters Into Licensing Agreement With Abbott Labs 36
Hennepin County Medical Center, University of Minnesota and Abbott Labs Enter into Agreement 37
AstraZeneca Enters into Co-Development Agreement with Abbott Labs 38
ALK-Abello Expands Partnership with Abbott Labs 39
Advanced Biological Enters into Agreement with Abbott for HIV Genotyping Data Analysis Software 40
Abbott Labs Enters into Co-Development Agreement with US Department of Defense 41
Abbott Molecular Enters into Co-Development Agreement with Biocartis 42
Abbott Enters Into Distribution Agreement With WhanIn For Depakote 43
Astellas Pharma Global Development Enters Into Co-Development Agreement With Abbott Labs For Cytomegalovirus Vaccine Trial 44
ChemDiv Research Institute Expands Co-Development Agreement with Abbott Labs 45
biOasis Technologies Enters Into Research Agreement With Abbott Labs 46
Abbott India Enters Into Joint Venture Agreement With Syngene International 47
Abbott Enters Into Co-Development Agreement With Galapagos For Autoimmune Disease Drug 48
DNDi Enters Into Co-Development Agreement With Abbott Labs For Neglected Tropical Diseases 49
Abbott Labs Enters Into Co-Development Agreement With Yeda Research 50
Astellas Pharma Enters Into Distribution Agreement With Abbott Japan For Luvox 51
Abbott Labs Enters Into Co-Development Agreement With Biotest For BT-061 52
Seattle Genetics Enters Into Collaboration With Abbott 54
Partners In Health Forms Joint Venture With Abbott Labs And Abbott Fund 55
Licensing Agreements 56
Novartis Enters into Licensing Agreement with Abbott Vascular for Everolimus 56
Abbott India Enters into Licensing Agreement with Bharat Biotech 58
Abbott Molecular Enters into Licensing Agreement with Institut Curie 59
Sepstone Enters into Licensing Agreement with Abbott Labs 60
Zealand Pharma Enters Into Licensing Agreement With Abbott Labs For AP214 61
Apricus Biosciences Enters Into Licensing Agreement With Abbott Labs For Vitaros 62
Abbott Labs Enters Into Licensing Agreement With Pfizer 63
Lupin Enters Into Patent Licensing Agreement With Abbott For Antara 64
Equity Offering 65
Abbott Labs Plans to Raise USD3 Billion in Public Offering of Shares 65
Abbott Sells stock of Mylan for USD2.29 Billion 66
AbbVie Spin Out from Abbott Laboratories 67
CFR Pharma Completes IPO For US$373.3 Million 68
Debt Offering 69
Abbott Labs Raises USD1.65 Billion in Public Offering of 4.75% Notes due 2036 69
Abbott Labs Raises USD2.85 Billion in Public Offering of 2.9% Notes due 2021 71
Abbott Labs Raises USD2.85 Billion in Public Offering of 2.35% Notes due 2019 73
Abbott Labs Raises USD3.25 Billion in Public Offering of 4.9% Notes due 2046 75
Abbott Labs Raises USD3 Billion in Public Offering of 3.75% Notes due 2026 77
Abbott Labs Raises USD1.5 Billion in Public Offering of 3.4% Notes Due 2023 79
Abbott Labs Raises USD750 Million in Public Offering of 2.55% Notes Due 2022 81
Abbott Labs Raises USD1 Billion in Public Offering of 2.55% Notes Due 2025 82
Abbott Labs Raises USD2.5 Billion in Public Offering of 2% Notes Due 2020 83
CFR International Completes Public Offering Of Notes For US$300 Million 84
Abbott Completes Private Placement Of Notes Due 2015 For US$500 Million 85
Abbott Completes Private Placement Of Notes Due 2015 For US$3.5 Billion 86
Abbott Completes Private Placement Of Notes Due 2017 For US$4 Billion 88
Abbott Completes Private Placement Of Notes Due 2042 For US$2.6 Billion 90
Abbott Completes Private Placement Of Notes Due 2018 For US$1 Billion 92
Abbott Completes Private Placement Of Notes Due 2022 For US$3.1 Billion 94
Abbott Labs Completes Private Placement Of Convertible Debt For US$0.1 Million 96
Asset Transactions 97
Abbott India May Sell Low-End Brands 97
Mylan Acquires Branded Generics Business of Abbott for USD5.3 Billion 98
Zoetis Acquires Animal Health Assets of Abbott for USD255 Million 100
Abbott Labs Rumored To Divest Part Of Generic Drug Business 101
Acquisition 102
Abbott Labs Acquires Alere 102
Johnson & Johnson Acquires Abbott Medical Optics from Abbott Laboratories for USD4.32 Billion 105
Abbott Labs Acquires CFR Pharma for USD2.9 Billion 106
Jude Medical Completes Acquisition of NeuroTherm for USD200 Million 108
Abbott Labs to Acquire Veropharm from Roman Avdeev for up to USD496 Million 109
GardenHills Completes Acquisition Of Additional 29.09% Interest In Veropharm For US$86.3 Million 110
GardenHills To Acquire 47.99% Stake In Verofarm 112
Pfizer, Novartis And Abbott Labs Reportedly Plan To Bid For Ache Labs 113
Abbott, Johnson & Johnson And Sanofi Mull Individual Acquisition Of Bausch & Lomb 115
CFR Pharma Acquires Laboratorio Franco Colombiano Lafrancol And Its Subsidiaries 117
AFK Sistema Plans To Acquire 51.8% Stake In Veropharm From Aptechnaya set’ 36,6 118
Russian Authorities Reject Abbott’s Bid To Acquire 62.5% Stake In Petrovax Pharm, Drug Manufacturer 119
CFR Pharma Acquires 50% Stake In Stellence For US$21 Million 121
STARLIMS Technologies Acquires Distribution Partners 122
CFR Pharma Acquires 41.88% Stake In Domesco Medical For US$14.4 Million 123
Chemo Group Acquires Remaining 50% Joint Venture Stake In Laboratorios Elea Mexico 124
Chemo Group Acquires Remaining 50% Joint Venture Stake In Servicios Elche 125
Chemo Group Acquires Remaining 50% Stake In Sinensix Pharma (Thailand) 126
CFR Pharma Acquires 50.79% Stake In Uman Pharma For US$26.5 Million 127
Gilead Sciences Acquires Arresto Biosciences 128
Abbott Laboratories – Key Competitors 130
Abbott Laboratories – Key Employees 131
Abbott Laboratories – Locations And Subsidiaries 133
Head Office 133
Other Locations & Subsidiaries 133
Recent Developments 151
Financial Announcements 151
Oct 18, 2017: Abbott Reports Third-Quarter 2017 Results 151
Jul 20, 2017: Abbott Reports Second-Quarter 2017 Results 154
Apr 19, 2017: Abbott Reports First-Quarter 2017 Results 156
Oct 19, 2016: Abbott Reports Third-Quarter 2016 Results 158
Jul 20, 2016: Abbott Reports Second-Quarter 2016 Results 161
Apr 20, 2016: Abbott Reports First-Quarter 2016 Results 164
Corporate Communications 167
Sep 22, 2017: Abbott and the Abbott Fund Provide $2 Million in Additional Relief to Help Families Affected by Hurricane Maria and the Earthquake in Central Mexico 167
Sep 18, 2017: Abbott and the Abbott Fund Expand Support for Hurricane Relief With $1 Million to Help Families Affected by Hurricane Irma 168
Aug 29, 2017: Abbott and the Abbott Fund Donate $1 Million to Support Hurricane Harvey Relief Efforts 169
Government and Public Interest 170
Feb 23, 2017: First Ever Cannabis-Based ETF to Include PharmaCyte Biotech, Abbott Laboratories, and GW Pharmaceuticals 170
Product News 171
Jul 18, 2016: Publication of HPTN 052 final results 171
Apr 07, 2016: Abbott Launches Eas Myoplex Sports Nutrition Line Designed For Performance 172
Mar 29, 2016: Abbott Introduces EnsureEnlive, Pairing the Latest in Science and Nutrition to Improve Health 173
Jan 18, 2016: Specialized nutrition supplement is associated with a 50 percent lower death rate in patients with heart or lung disease, new study shows 174
Appendix 176
Methodology 176
About GlobalData 176
Contact Us 176
Disclaimer 176
Abbott Laboratories, Pharmaceuticals & Healthcare, Key Facts, 2016 2
Abbott Laboratories, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 8
Abbott Laboratories, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 9
Abbott Laboratories, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 10
Abbott Laboratories, Deals By Therapy Area, 2011 to YTD 2017 11
Abbott Laboratories, Medical Devices Deals, 2011 to YTD 2017 13
Abbott Laboratories, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 14
Abbott Labs And Organon BioSciences Plan To Acquire Certain Pharma Assets From Johnson & Johnson 20
Thoratec Acquires DuraHeart II Ventricular Assist System From Terumo For US$56.5 Million 22
Abbott Labs Acquires AP214 From Action Pharma For US$110 Million 24
NeuroGenetic Pharma Raises US$0.2 Million In Venture Financing 26
NeuroGenetic Pharma Secures Investment In Venture Financing 27
AuraSense Therapeutics Secures Investment In Series B Financing 28
Creabilis Secures US$20 Million In Series B Financing 29
AM-Pharma Secures US$39.7 Million In Series D Financing 30
Spinal Modulation Secures US$30 Million In Series D Financing 32
Sanofi Plans to Sell Portfolio of Mature Drugs for USD8.6 Billion 34
BioPorto Diagnostics Enters Into Licensing Agreement With Abbott Labs 36
Hennepin County Medical Center, University of Minnesota and Abbott Labs Enter into Agreement 37
AstraZeneca Enters into Co-Development Agreement with Abbott Labs 38
ALK-Abello Expands Partnership with Abbott Labs 39
Advanced Biological Enters into Agreement with Abbott for HIV Genotyping Data Analysis Software 40
Abbott Labs Enters into Co-Development Agreement with US Department of Defense 41
Abbott Molecular Enters into Co-Development Agreement with Biocartis 42
Abbott Enters Into Distribution Agreement With WhanIn For Depakote 43
Astellas Pharma Global Development Enters Into Co-Development Agreement With Abbott Labs For Cytomegalovirus Vaccine Trial 44
ChemDiv Research Institute Expands Co-Development Agreement with Abbott Labs 45
biOasis Technologies Enters Into Research Agreement With Abbott Labs 46
Abbott India Enters Into Joint Venture Agreement With Syngene International 47
Abbott Enters Into Co-Development Agreement With Galapagos For Autoimmune Disease Drug 48
DNDi Enters Into Co-Development Agreement With Abbott Labs For Neglected Tropical Diseases 49
Abbott Labs Enters Into Co-Development Agreement With Yeda Research 50
Astellas Pharma Enters Into Distribution Agreement With Abbott Japan For Luvox 51
Abbott Labs Enters Into Co-Development Agreement With Biotest For BT-061 52
Seattle Genetics Enters Into Collaboration With Abbott 54
Partners In Health Forms Joint Venture With Abbott Labs And Abbott Fund 55
Novartis Enters into Licensing Agreement with Abbott Vascular for Everolimus 56
Abbott India Enters into Licensing Agreement with Bharat Biotech 58
Abbott Molecular Enters into Licensing Agreement with Institut Curie 59
Sepstone Enters into Licensing Agreement with Abbott Labs 60
Zealand Pharma Enters Into Licensing Agreement With Abbott Labs For AP214 61
Apricus Biosciences Enters Into Licensing Agreement With Abbott Labs For Vitaros 62
Abbott Labs Enters Into Licensing Agreement With Pfizer 63
Lupin Enters Into Patent Licensing Agreement With Abbott For Antara 64
Abbott Labs Plans to Raise USD3 Billion in Public Offering of Shares 65
Abbott Sells stock of Mylan for USD2.29 Billion 66
AbbVie Spin Out from Abbott Laboratories 67
CFR Pharma Completes IPO For US$373.3 Million 68
Abbott Labs Raises USD1.65 Billion in Public Offering of 4.75% Notes due 2036 69
Abbott Labs Raises USD2.85 Billion in Public Offering of 2.9% Notes due 2021 71
Abbott Labs Raises USD2.85 Billion in Public Offering of 2.35% Notes due 2019 73
Abbott Labs Raises USD3.25 Billion in Public Offering of 4.9% Notes due 2046 75
Abbott Labs Raises USD3 Billion in Public Offering of 3.75% Notes due 2026 77
Abbott Labs Raises USD1.5 Billion in Public Offering of 3.4% Notes Due 2023 79
Abbott Labs Raises USD750 Million in Public Offering of 2.55% Notes Due 2022 81
Abbott Labs Raises USD1 Billion in Public Offering of 2.55% Notes Due 2025 82
Abbott Labs Raises USD2.5 Billion in Public Offering of 2% Notes Due 2020 83
CFR International Completes Public Offering Of Notes For US$300 Million 84
Abbott Completes Private Placement Of Notes Due 2015 For US$500 Million 85
Abbott Completes Private Placement Of Notes Due 2015 For US$3.5 Billion 86
Abbott Completes Private Placement Of Notes Due 2017 For US$4 Billion 88
Abbott Completes Private Placement Of Notes Due 2042 For US$2.6 Billion 90
Abbott Completes Private Placement Of Notes Due 2018 For US$1 Billion 92
Abbott Completes Private Placement Of Notes Due 2022 For US$3.1 Billion 94
Abbott Labs Completes Private Placement Of Convertible Debt For US$0.1 Million 96
Abbott India May Sell Low-End Brands 97
Mylan Acquires Branded Generics Business of Abbott for USD5.3 Billion 98
Zoetis Acquires Animal Health Assets of Abbott for USD255 Million 100
Abbott Labs Rumored To Divest Part Of Generic Drug Business 101
Abbott Labs Acquires Alere 102
Johnson & Johnson Acquires Abbott Medical Optics from Abbott Laboratories for USD4.32 Billion 105
Abbott Labs Acquires CFR Pharma for USD2.9 Billion 106
Jude Medical Completes Acquisition of NeuroTherm for USD200 Million 108
Abbott Labs to Acquire Veropharm from Roman Avdeev for up to USD496 Million 109
GardenHills Completes Acquisition Of Additional 29.09% Interest In Veropharm For US$86.3 Million 110
GardenHills To Acquire 47.99% Stake In Verofarm 112
Pfizer, Novartis And Abbott Labs Reportedly Plan To Bid For Ache Labs 113
Abbott, Johnson & Johnson And Sanofi Mull Individual Acquisition Of Bausch & Lomb 115
CFR Pharma Acquires Laboratorio Franco Colombiano Lafrancol And Its Subsidiaries 117
AFK Sistema Plans To Acquire 51.8% Stake In Veropharm From Aptechnaya set' 36,6 118
Russian Authorities Reject Abbott's Bid To Acquire 62.5% Stake In Petrovax Pharm, Drug Manufacturer 119
CFR Pharma Acquires 50% Stake In Stellence For US$21 Million 121
STARLIMS Technologies Acquires Distribution Partners 122
CFR Pharma Acquires 41.88% Stake In Domesco Medical For US$14.4 Million 123
Chemo Group Acquires Remaining 50% Joint Venture Stake In Laboratorios Elea Mexico 124
Chemo Group Acquires Remaining 50% Joint Venture Stake In Servicios Elche 125
Chemo Group Acquires Remaining 50% Stake In Sinensix Pharma (Thailand) 126
CFR Pharma Acquires 50.79% Stake In Uman Pharma For US$26.5 Million 127
Gilead Sciences Acquires Arresto Biosciences 128
Abbott Laboratories, Key Competitors 130
Abbott Laboratories, Key Employees 131
Abbott Laboratories, Other Locations 133
Abbott Laboratories, Subsidiaries 133